Trials that use: P-values
New to this method? Read the tutorial →
10,701 results
- EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia: Complete Statistical AnalysisIndependent statistical analysis of EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: primary endpoint results, effect estimate with…
- Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EXAMINERIndependent statistical analysis of A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing: Complete Statistical AnalysisIndependent statistical analysis of Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07074171).
- Examining the Impact of Family Connectors: Complete Statistical AnalysisIndependent statistical analysis of Examining the Impact of Family Connectors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05195489).
- ExCelA complete statistical analysis of the ExCel phase 3 trial of exemestane for breast cancer prevention in postmenopausal women at increased risk, including trial design, breast cancer-free survival, hazard ratios, confidence intervals,…
- ExCeLIndependent statistical analysis of EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EXCELIndependent statistical analysis of Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00810797).
- Exenatide in Extreme Pediatric Obesity: Complete Statistical AnalysisIndependent statistical analysis of Exenatide in Extreme Pediatric Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01237197).
- Exercise and QUality Diet After Leukemia: The EQUAL Study: Complete Statistical AnalysisIndependent statistical analysis of Exercise and QUality Diet After Leukemia: The EQUAL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02244411).
- Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03355469).
- Exercise for Swallowing Problems After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Exercise for Swallowing Problems After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00722111).
- Exercise From Afar: Progressing At Risk Individuals to Independent Exercise: Complete Statistical AnalysisIndependent statistical analysis of Exercise From Afar: Progressing At Risk Individuals to Independent Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06667817).
- Exercise Pulmonary Transit Time: Complete Statistical AnalysisIndependent statistical analysis of Exercise Pulmonary Transit Time: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04336995).
- Exercise Training and Cognitive Function in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Exercise Training and Cognitive Function in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03197038).
- Exercise Training in Heart Failure: Changes in Cardiac Structure and Function: Complete Statistical AnalysisIndependent statistical analysis of Exercise Training in Heart Failure: Changes in Cardiac Structure and Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exercise Training to Improve Cognitive Function: Complete Statistical AnalysisIndependent statistical analysis of Exercise Training to Improve Cognitive Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03824639).
- Exercise-induced Hypoalgesia After Comparative Forms of Exercise: Complete Statistical AnalysisIndependent statistical analysis of Exercise-induced Hypoalgesia After Comparative Forms of Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01883895).
- Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload: Complete Statistical AnalysisIndependent statistical analysis of Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: Complete Statistical AnalysisIndependent statistical analysis of Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: primary endpoint results,…
- Exparel for Total Shoulder Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Exparel for Total Shoulder Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04364867).
- Exparel vs. Standard Bupivicaine for Abdominoplasty: Complete Statistical AnalysisIndependent statistical analysis of Exparel vs. Standard Bupivicaine for Abdominoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01853176).
- Expectation of Unpleasant Events in Anxiety Disorders: Complete Statistical AnalysisIndependent statistical analysis of Expectation of Unpleasant Events in Anxiety Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00055224).
- EXPEDITEComplete statistical analysis of the EXPEDITE phase 3 trial comparing misoprostol vaginal insert with dinoprostone vaginal insert for reducing time to vaginal delivery during induction of labor.
- ExpeditionPROIndependent statistical analysis of A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.: Complete Statistical AnalysisIndependent statistical analysis of Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: Complete Statistical AnalysisIndependent statistical analysis of Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00752089).
- Expiratory Muscle Training in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Expiratory Muscle Training in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04569968).
- Exploration of Pupil Dilation in Horner’s Patients Taking Flomax: Complete Statistical AnalysisIndependent statistical analysis of Exploration of Pupil Dilation in Horner's Patients Taking Flomax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03615508).
- Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: Complete Statistical AnalysisIndependent statistical analysis of Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Exploratory Study for Toivoa-001 on Human Factors: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study for Toivoa-001 on Human Factors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06477913).
- Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Exploratory Study of OPC-12759 Ophthalmic Suspension: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study of OPC-12759 Ophthalmic Suspension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01493180).
- Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD): Complete Statistical AnalysisIndependent statistical analysis of Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: Complete Statistical AnalysisIndependent statistical analysis of Exploratory Subjective Sleep Study of a Prototype Nasal Dilator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01122849).
- EXPLOREIndependent statistical analysis of EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Exploring Life Experience and Lifestyle Intervention Program Among Patients With CKD: Complete Statistical AnalysisIndependent statistical analysis of Exploring Life Experience and Lifestyle Intervention Program Among Patients With CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exploring the Effects of Corticosteroids on the Human Hippocampus: Complete Statistical AnalysisIndependent statistical analysis of Exploring the Effects of Corticosteroids on the Human Hippocampus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03896659).
- Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures: primary endpoint results, effect estimate with…
- Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety: Complete Statistical AnalysisIndependent statistical analysis of Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00842946).
- ExRx in FAIndependent statistical analysis of NAD+ and Exercise in FA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04192136).
- EXSCELA detailed independent statistical analysis of EXSCEL, the phase 3 trial of exenatide once weekly versus placebo in patients with type 2 diabetes mellitus, including its randomized design, time-to-event endpoints, Cox models,…
- EXT-HFIndependent statistical analysis of Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EXTAXIndependent statistical analysis of Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- EXTENDIndependent statistical analysis of Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02725528).